目的: 此回溯性研究分析吸入性colistin 用於加護病房重症病人因多重抗藥性革蘭氏陰性菌導致
呼吸器相關肺炎的治療結果與副作用. 方法: 由某區域教學醫院篩選自2010 年3 月1 日至2011 …

Background: Recently ventilator-associated pneumonia (VAP) caused by multi-drug
resistant (MDR) gram-negative bacteria has been increasing. Meanwhile the colistin is …

BACKGROUND: Ventilator-associated pneumonia (VAP) remains the leading cause of
death in patients with intensive care unit (ICU) acquired infections associated with an …

Ventilator-associated pneumonia (VAP) as a result of multidrug-resistant Gram-negative
bacteria has contributed to the revival of the use of intravenous (iv) colistin. However, the …

Background: Infections caused by multidrug-resistant (MDR) pathogen have caused a
resurgence of interest in colistin. To date, information about the effectiveness of Aerosolized …

Objective: Aerosolized colistin has been used for multidrug-resistant gram-negative bacilli
pneumonia. The aim of this study was to compare the clinical response and microbiological …

Background: Despite the increasing use of colistin in clinical practice, the optimal dosing,
and administration route have not been established. This study aimed to evaluate the …

Introduction: Colistin is used to treat hospital-acquired pneumonia and ventilator-associated
pneumonia. However, direct drug deposition at the site of infection may improve its efficacy …

Hospital-acquired pneumoniae and ventilatory-associated pneumoniae (VAP) were the
most common health-care associated infections leading to high mortality rates. Intravenous …

Objectives. The incidence of ventilator-associated pneumonia (VAP) due to multidrug-
resistant (MDR) organisms is increasing. Intravenous (IV) colistin or aerosolized (AS) plus IV …